Press Release: Stemvax : Innovest Global Enters into Agreement for the Sale of StemVax Therapeutics to XsunX, Inc.

StemVax Public Spinoff Complete Upon Completion of Reverse Stock Split; Transaction to Notably Strengthen Innovest Global Balance Sheet CLEVELAND, OH / ACCESSWIRE / August 11, 2020 / Innovest Global Inc. (OTCPINK:IVST), a diversified industrials company, today announced it has entered into an agreement to sell StemVax Therapeutics, a biotechnology company developing novel therapies for brain tumor patients to XsunX, Inc. (OTC